{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:50:37Z","timestamp":1782377437265,"version":"3.54.5"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Minor acute ischemic stroke (mAIS), typically defined as a National Institutes of Health Stroke Scale (NIHSS) score \u2264 5, accounts for over 50% of all ischemic strokes. However, the optimal pharmacological therapy for patients with mAIS remains controversial. Hence, this systematic review and network meta-analysis (NMA) was conducted to compare the effectiveness and safety of available pharmacological therapies for mAIS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, the Cochrane Library, and Web of Science databases were systematically searched for publications up to June 1, 2025. Randomized controlled trials (RCTs) and cohort studies investigating various antithrombotic drugs for mAIS were retrieved. The included outcome measures were functional outcomes (modified Rankin Scale [mRS] 0\u20131, mRS 0\u20132), early neurological improvement within 24\u202fh, intracranial hemorrhage, newly diagnosed ischemic stroke within 90\u202fdays, and all-cause mortality (ACM). Bayesian NMA was performed using R 4.5.1 and STATA 15.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven eligible studies, involving 26,176 patients, were included, which evaluated 9 different antithrombotic interventions. According to the NMA, single antiplatelet therapy (SAPT) (surface under the cumulative ranking curve [SUCRA]\u202f=\u202f67.3%) and aspirin (SUCRA\u202f=\u202f71.9%) were the most likely best interventions for achieving an mRS score of 0\u20131 and 0\u20132, respectively. Alteplase (SUCRA\u202f=\u202f81.9%) had the highest probability of being the most effective in improving early neurological function within 24\u202fh. Aspirin (SUCRA\u202f=\u202f87.6%) was associated with the lowest incidence of symptomatic intracranial hemorrhage. Dual antiplatelet therapy (DAPT) represented the most likely best intervention in reducing newly diagnosed ischemic stroke within 90\u202fdays and ACM, with a SUCRA of 87.7 and 68.3%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both DAPT and aspirin may represent safe and effective interventions for treating mAIS. However, individual patient circumstances should be considered in clinical decision-making. This analysis provides insights that may support the selection of individualized treatment strategies. The findings of this NMA, based on limited studies, remain to be further validated in future well-designed large-scale RCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/search<\/jats:ext-link>\n                      , identifier CRD420251238111.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1834958","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:33:12Z","timestamp":1782376392000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimal pharmacological therapy for minor acute ischemic stroke: a network meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Shuo","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Neurology, Shenyang Sujiatun District Central Hospital","place":["Shenyang City, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenyang Sujiatun District Central Hospital","place":["Shenyang City, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenyang Sujiatun District Central Hospital","place":["Shenyang City, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boru","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenyang Sujiatun District Central Hospital","place":["Shenyang City, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenyang Sujiatun District Central Hospital","place":["Shenyang City, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e214105","DOI":"10.1212\/wnl.0000000000214105","article-title":"Comparative rates of acute ischemic stroke incidence: native Hawaiians or Pacific islanders vs other races and ethnic groups in 4 US states","volume":"105","author":"Otite","year":"2025","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e213979","DOI":"10.1212\/wnl.0000000000213979","article-title":"Association between Food Desert residence and ischemic stroke risk: a population-based study","volume":"105","author":"Becker","year":"2025","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/17474930241273685","article-title":"Early neurological deterioration in acute lacunar ischemic stroke: systematic review of incidence, mechanisms, and prospects for treatment","volume":"20","author":"Werring","year":"2025","journal-title":"Int J Stroke"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"I-lxii","DOI":"10.1177\/2396987321989865","article-title":"European stroke organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur Stroke J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e003097","DOI":"10.1136\/svn-2024-003097","article-title":"Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis","volume":"10","author":"Qin","year":"2025","journal-title":"Stroke Vasc Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e2411735","DOI":"10.1001\/jamanetworkopen.2024.11735","article-title":"Comparison of dual antiplatelet therapies for minor, nondisabling, acute ischemic stroke: a Bayesian network Meta-analysis","volume":"7","author":"Lim","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/str.0000000000000513","article-title":"2026 guideline for the early Management of Patients with Acute Ischemic Stroke: a guideline from the American Heart Association\/American Stroke Association","author":"Prabhakaran","year":"2026","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1001\/jama.2023.7827","article-title":"Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"k5108","DOI":"10.1136\/bmj.k5108","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","volume":"363","author":"Hao","year":"2018","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11239-024-02994-z","article-title":"Dual antiplatelet therapy vs alteplase in adult patients with acute minor ischemic stroke: a systematic review and Meta-analysis","volume":"57","author":"Viana","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref14","author":"Julian","year":"2022"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0272989x12455847","article-title":"Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Mak"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"f2914","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"Mills","year":"2013","journal-title":"BMJ"},{"key":"ref18","volume-title":"Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment","author":"Dias","year":"2012"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/978-1-62703-059-5_25","article-title":"Bayesian inference","volume":"930","author":"Bois","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ije\/dyt043","article-title":"Markov chain Monte Carlo: an introduction for epidemiologists","volume":"42","author":"Hamra","year":"2013","journal-title":"Int J Epidemiol"},{"key":"ref21","volume-title":"NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-analysis of Randomised Controlled Trials","author":"Dias","year":"2014"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12936-017-1963-0","article-title":"Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis","volume":"16","author":"Whegang Youdom","year":"2017","journal-title":"Malar J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.7326\/m15-2521","article-title":"Uncertainty in treatment rankings: reanalysis of network Meta-analyses of randomized trials","volume":"164","author":"Trinquart","year":"2016","journal-title":"Ann Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e2017047","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiol Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/strokeaha.109.564906","article-title":"Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis","volume":"41","author":"Bath","year":"2010","journal-title":"Stroke"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial","volume":"320","author":"Khatri","year":"2018","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/00207454.2019.1707822","article-title":"Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke","volume":"130","author":"Lan","year":"2020","journal-title":"Int J Neurosci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/svn-2020-000841","article-title":"Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke","volume":"7","author":"Kim","year":"2022","journal-title":"Stroke Vasc Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","article-title":"Dual antiplatelet treatment up to 72 hours after ischemic stroke","volume":"389","author":"Gao","year":"2023","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e933","DOI":"10.1212\/wnl.0000000000207538","article-title":"IV thrombolysis vs early dual antiplatelet therapy in patients with mild noncardioembolic ischemic stroke","volume":"101","author":"Sykora","year":"2023","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamaneurol.2023.1262","article-title":"Safety and efficacy of dual thrombolytic therapy with mutant Prourokinase and small bolus alteplase for ischemic stroke: a randomized clinical trial","volume":"80","author":"van der Ende","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"107903","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107903","article-title":"Early dual antiplatelet therapy in patients with minor ischemic stroke after intravenous thrombolysis","volume":"33","author":"Alet","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1363358","DOI":"10.3389\/fneur.2024.1363358","article-title":"The effect of argatroban on early neurological deterioration and outcomes in minor ischemic stroke: preliminary findings","volume":"15","author":"Jin","year":"2024","journal-title":"Front Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/1747493019832998","article-title":"Antiplatelet vs. R-tPA for acute mild ischemic stroke: a prospective, random, and open label multi-center study","volume":"14","author":"Wang","year":"2019","journal-title":"Int J Stroke"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s41598-025-85969-1","article-title":"Comparison of the safety and efficacy of dual antiplatelet therapy versus tenecteplase in patients with minor nondisabling acute ischemic stroke","volume":"15","author":"Jiang","year":"2025","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"114159","DOI":"10.1016\/j.jconrel.2025.114159","article-title":"Fibrin-targeted ROS-scavenging micelles with photothermal and NO delivery for thrombolysis and post-thrombotic vascular remodeling","volume":"386","author":"Xue","year":"2025","journal-title":"J Control Release"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s10143-025-03786-6","article-title":"Intravenous thrombolysis before endovascular therapy for acute ischemic stroke due to tandem lesions: a systematic review and meta-analysis","volume":"48","author":"Rodriguez-Calienes","year":"2025","journal-title":"Neurosurg Rev"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12031-025-02443-3","article-title":"Tissue plasminogen activator as an approved strategy for ischemic stroke: a review of tPA's structure, mechanism of action and the novel targeting methods","volume":"75","author":"Didehvar","year":"2025","journal-title":"J Mol Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/svn-2020-000791","article-title":"Clopidogrel with aspirin in high-risk patients with acute non-disabling cerebrovascular events II (CHANCE-2): rationale and design of a multicentre randomised trial","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3760\/cma.j.cn113694-20240410-00221","article-title":"Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023","volume":"57","year":"2024","journal-title":"Chin J Neurol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/s0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00415-025-13210-0","article-title":"Comparative efficacy and safety of different durations of dual antiplatelet therapy in acute minor non-cardioembolic stroke: a systematic review and network meta-analysis","volume":"272","author":"Liu","year":"2025","journal-title":"J Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jama.2022.12584","article-title":"Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke: the RESCUE BT randomized clinical trial","volume":"328","author":"Qiu","year":"2022","journal-title":"JAMA"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1834958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:33:15Z","timestamp":1782376395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1834958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":45,"alternative-id":["10.3389\/fneur.2026.1834958"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1834958","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1834958"}}